Substantial Protective Immunity Conferred by a Combination of Brucella abortus Recombinant Proteins against Brucella abortus 544 Infection in BALB/c Mice
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Chronic infection with intracellular Brucella abortus (B. abortus) in livestock remains as a major problem worldwide. Thus, the search for an ideal vaccine is still ongoing. In this study, we evaluated the protective efficacy of a combination of B. abortus recombinant proteins; superoxide dismutase (rSodC), riboflavin synthase subunit beta (rRibH), nucleoside diphosphate kinase (rNdk), 50S ribosomal protein (rL7/L12) and malate dehydrogenase (rMDH), cloned and expressed into a pMal vector system and DH5α, respectively, and further purified and applied intraperitoneally into BALB/c mice. After first immunization and two boosters, mice were infected intraperitoneally (IP) with 5 × 104 CFU of virulent B. abortus 544. Spleens were harvested and bacterial loads were evaluated at two weeks post-infection. Results revealed that this combination showed significant reduction in bacterial colonization in the spleen with a log protection unit of 1.31, which is comparable to the average protection conferred by the widely used live attenuated vaccine RB51. Cytokine analysis exhibited enhancement of cell-mediated immune response as IFN-γ is significantly elevated while IL-10, which is considered beneficial to the pathogen’s survival, was reduced compared to control group. Furthermore, both titers of IgG1 and IgG2a were significantly elevated at three and four-week time points from first immunization. In summary, our in vivo data revealed that vaccination with a combination of five different proteins conferred a heightened host response to Brucella infection through cell-mediated immunity which is desirable in the control of intracellular pathogens. Thus, this combination might be considered for further improvement as a potential candidate vaccine against Brucella infection.
Abstract
Chronic infection with intracellular Brucella abortus (B. abortus) in livestock remains as a major problem worldwide. Thus, the search for an ideal vaccine is still ongoing. In this study, we evaluated the protective efficacy of a combination of B. abortus recombinant proteins; superoxide dismutase (rSodC), riboflavin synthase subunit beta (rRibH), nucleoside diphosphate kinase (rNdk), 50S ribosomal protein (rL7/L12) and malate dehydrogenase (rMDH), cloned and expressed into a pMal vector system and DH5α, respectively, and further purified and applied intraperitoneally into BALB/c mice. After first immunization and two boosters, mice were infected intraperitoneally (IP) with 5 × 104 CFU of virulent B. abortus 544. Spleens were harvested and bacterial loads were evaluated at two weeks post-infection. Results revealed that this combination showed significant reduction in bacterial colonization in the spleen with a log protection unit of 1.31, which is comparable to the average protection conferred by the widely used live attenuated vaccine RB51. Cytokine analysis exhibited enhancement of cell-mediated immune response as IFN-γ is significantly elevated while IL-10, which is considered beneficial to the pathogen’s survival, was reduced compared to control group. Furthermore, both titers of IgG1 and IgG2a were significantly elevated at three and four-week time points from first immunization. In summary, our in vivo data revealed that vaccination with a combination of five different proteins conferred a heightened host response to Brucella infection through cell-mediated immunity which is desirable in the control of intracellular pathogens. Thus, this combination might be considered for further improvement as a potential candidate vaccine against Brucella infection.
참고문헌 (44)
- Hop HT, "Immunogenicity and protective effect of recombinant Brucella abortus Ndk(rNdk)against a virulent strain Brucella abortus 544 infection in BALB", c mice, 2015, pp.362, 1~6
- Trujillo IZ, "Brucellosis", Infect, Dis. Clin. North. Am, 8, pp.225~241 (1994)
- Franco MP, "Human brucellosis", Lance, Infect. Dis, 7, pp.775~786 (2007)
- Ko J, "Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans", Clin. Microbiol. Rev, 16, pp.65~78 (2003)
- Corbel MJ, "Brucellosis : an overview", Emerg. Infect. Dis, 3, pp.213~221 (1997)
- Sangari FJ, "Molecular basis of Brucella pathogenicity : an update", Microbiologia, 12, pp.207~218 (1996)
- Baldwin CL, "Macrophages and Brucella", Immunol. Ser, 60, pp.363~380 (1994)
- Ebel ED, "Estimating herd prevalence of bovine brucellosis in 46 USA states using slaughter surveillance", Prev. Vet. Med, 85, pp.295~316 (2008)
- Treanor JJ, "Vaccination strategies for managing brucellosis in Yellowstone bison", Vaccine, 28, pp.F64~F72 (2010)
- Galindo RC, "Gene expression changes in spleens of the wildlife reservoir species, Eurasian wild boar(Sus scrofa), naturally infected Brucella suis biovar 2", J. Genet. Genomics, 37, pp.725~736 (2010)
- Olsen SC, "Immune responses and protection against experimental Brucella suis biovar 1challenge in non-vaccinated cattle", Clin. Vaccine Immunol, 17, pp.1891~1895 (2010)
- Perrie Y, "Vaccine adjuvant systems : enhancing the efficacy of sub-unit protein antigens", Int. J. Pharm, 364, pp.272~280 (2008)
- Arena-Gamboa AM, "Immunization with a single dose of a microencapsulated Brucella melitensis m u atnt e nhances protection against wild-type challenge", Immun. Infect, 76, pp.2448~2255 (2008)
- Rafiei A, "Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease", J. Infect, 53, pp.315~324 (2006)
- REYESALISHA WEHDNESDAY, "Molecular cloning, purification and immunogenicity of recombinant Brucella abortus 544 malate dehydrogenase protein", Journal of Veterinary Science, 17(1), pp.119~122 (2016), 대한수의학회[DOI]
- Velikovsky CA, "Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544independently of the adjuvant formulation used", Infect. Immun, 71, pp.5750~5755 (2003)
- Stevens MG, "Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice", Infect. Immun, 60, pp.4407~4409 (1992)
- Oliveira SC, "Immunization of mice with recombinant L7", L12 ribosomal protein confers protection against Brucella abortus infection, 1996, pp.14, 959~962
- Dubray G, "Isolation of three Brucella abortus cell wall antigens protective in murine experimental brucellosis", Ann. Rech. Vet, 11, pp.367~373 (1980)
- Jeong Ju Lim, "Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice", Journal of Veterinary Science, 13(3), pp.287~292 (2012), 대한수의학회[DOI]
- Miranda KL, "Brucella abortus S19 and RB51 vaccine immunogenicity test : evaluation of three mice(BALB", c, Swiss and CD-1)and two challenge strains(544 and 2308), 2015, pp.33, 507~511
- Schurig GG, "Brucellosis vaccines : past, present and future", Vet. Microbiol, 90, pp.479~496 (2002)
- Araya LN, "Temporal development of protective cell-mediated and humoral immunity in BALB", c mice infected with Brucella abortus, 1989, pp.143, 3330~3337
- Pavlov HM, "In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection", Cell. Immunol, 71, pp.127~138 (1982)
- Truong QL, "Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B, abortus and Brucella canis in BALB", c mice, 2015, pp.161, 2137~2148
- Bachrach G, "Brucella ribosomal protein L7", L12 is a major component in the antigenicity of Brucella in INRA for delayed-type hypersensitivity in Brucella-sensitized guinea pigs, 1994, pp.62, 5361~5366
- Gee J, "The Brucella abortus Cu, Zn superoxide dismutase is required for optimal resistance to oxidative killing by murine macrophages and wild-type virulence in experimentally infected mice", Infect. Immun, 73, pp.2873~2880 (2005)
- Tabatai L B, "Modul ation of immu ne responses in BALB", c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine, 1994, pp.12, 919~924
- Piddington DL, "Cu, Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst", Infect. Immun, 69, pp.4980~4987 (2001)
- De Groote MA, "Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH oxidase and nitric oxide synthase", Proc. Natl. Acad. Sci. USA, 94, pp.13997~14001 (1997)
- Velikovsky CA, "A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB", c mice, 2002, pp.70, 2507~2511
- Oliveira SC, "Confronting the barriers to develop vaccines against brucellosis", Expert. Rev. Vaccines, 10, pp.1291~1305 (2011)
- Godfroid J, "Brucellosis in the European Union and Norway at the turn of the twenty-first century", Vet. Microbiol, 90, pp.135~145 (2002)
- Perkins SD, "Towards a Brucella vaccine for humans", FEMS. Microbiol. Rev, 34, pp.379~394 (2010)
- Fugier E, "Virulence factors in brucellosis : implications for aetiopathogenesis and treatment", Expert. Rev. Mol. Med, 9, pp.1~10 (2007)
- Jiang X, "Iron augments macrophagemediated killing of Brucella abortus alone and in conjunction with IFN-γ", Cell. Immunol, 148, pp.397~407 (1993)
- Luo D, "Protective immunity elicited by a divalent DNA vaccine encoding both the L7", L12 and Omp16 genes of Brucella abortus in BALB, Infect. Immun, pp.2006, 74[DOI]
- Motaharinia Y, "Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum and heat-killed Brucella melitensis 16M", J. Microbiol. Immunol. Infect, 46, pp.253~258 (2013)
- Cassataro J, "Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection", Infect. Immun, 73, pp.8079~8088 (2005)
- Pasquevich KA, "Immunization with recombinant Brucella species outer membrane protein Omp16and Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection", Infect. Immun, 77, pp.436~445 (2009)
- Couper KN, "IL-10; the master regulator of immunity to infection", J. Immunol, 180, pp.5771~5777 (2008)
- Fernandez D M, "Interleu ink-10downregulates protective immunity to Brucella abortus", Infect. Immun, 63, pp.1130~1133 (1995)
- Corsetti P, "Lack of endogenous IL-10 enhances production of proinflammatory cytokines and leads to Brucella abortus clearance in mice", PLoS One, 8, pp.e74729~ (2013)
- Hop HT, "Immunization of BALB", c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus, 2018, pp.36, 3027~3033